Navigation Links
Adult stem cell breakthrough
Date:11/19/2008

The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.

These remarkable results provide crucial new evidence that adult stem cells, combined with biologically compatible materials, can offer genuine solutions to other serious illnesses.

In particular, the successful outcome shows it is possible to produce a tissue-engineered airway with mechanical properties that permit normal breathing and which is free from the risks of rejection seen with conventional transplanted organs. The patient has not developed antibodies to her graft, despite not taking any immunosuppressive drugs. Lung function tests performed two months after the operation were all at the better end of the normal range for a young woman.

The pan-European team from the universities of Barcelona, Bristol, Padua and Milan report on this pioneering work in an article published early online and in an upcoming edition of The Lancet.

The loss of a normal airway is devastating, but previous attempts to replace large airways have met serious problems. The 30-year-old mother of two, suffering from collapsed airways following a severe case of TB, was hospitalised in March 2008 with acute shortness of breath rendering her unable to carry out simple domestic duties or care for her children. The only conventional option remaining was a major operation to remove her left lung which carries a risk of complications and a high mortality rate.

Based on successful laboratory work previously performed by the team, and given the urgency of the situation, it was proposed that the lower trachea and the tube to the patient's left lung (bronchus) should be replaced with a bioengineered airway based on the scaffold of a human trachea.

A s
'/>"/>

Contact: Cherry Lewis
cherry.lewis@bristol.ac.uk
44-077-294-21885
University of Bristol
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. SNPs affect folate metabolism in study of Puerto-Rican adults
2. Scripps research scientists identify compounds for stem-cell production from adult cells
3. Turtle doves commit adultery
4. Efavirenz-based initial therapies associated with better outcomes in HIV-infected adults
5. NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells
6. Researchers discover atomic bomb effect results in adult-onset thyroid cancer
7. Adults who eat eggs for breakfast lose 65 percent more weight
8. Adult stem cells activated in mammalian brain
9. Childrens Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach
10. Salk researchers reprogram adult stem cells in their natural environment
11. U of M researchers discover gene linked to adult-onset obesity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... Ind. - Researchers at Purdue University have disc...fibers in spinal cord injuries using nano-spheres ...r an accident. , The synthetic "copolymer micell...in diameter, or roughly 100 times smaller than the...e been studying how to deliver drugs for cancer tr...
(Date:11/6/2009)...ration is now open for the Society of Intervention...gy (IO) Therapies" Webinar, which will provide the...treatment of liver tumors, kidney tumor ablation a...tion of physicians, scientists and allied health p...through pioneering advances in image-guided therap...
(Date:11/6/2009)...6 Auburn Hills, MI-based Law Enfor...talling its locker system and patent-pending Biome...Department of Health and Human Services, National ... The locker system will support the NIH,s entire p... nation,s medical research agency. The project is...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2EPA grant to University of Chicago for research on food allergy triggers 9332 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 1Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 3
...hiny amber jewelry and a mucky Florida swamp have ...m that could be anywhere from 15 million to 130 mi...f Florida and the Museum of Natural History in Ber...quatic critters such as beetles and small crustace...the water from pine-like trees. Their findings are...
...ber 17, 2007. -- It all started as a graduate scho...ire to figure out why things live where they do, s...ive in different places? Ive been studying the dis...ears. So I even made this question the basis of my...s. , That burning desire led Neilson to develop t...
... the leading cause of death due to infectious dise...lion people are currently infected, and although m... occur. This paper by Denise Kirschner and colleag...ducts virtual clinical trials to examine the cause... (TNF) is a protein that facilitates cellcell comm...
Other Biology News:Scientists find how amber becomes death trap for watery creatures 2Scientists find how amber becomes death trap for watery creatures 3Neilson member of Nobel Prize-winning panel of scientists 2
(Date:11/6/2009)...RNewswire-FirstCall/ -- ,, 3Q09 Corporate Hi...M) E.U. Marketing Authorization to Astellas Pharma...cial readiness activities Expanded management tea... and Director, Commercial Operations Appointed Br...ommittee chairman , Upcoming 2009 Milestone...
(Date:11/6/2009)...FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NAS...nounced updated results from a Phase II study of i...etastatic to the lung in a poster presentation at ... Meeting held in Miami Beach, Florida, from Novemb...A Phase II Study of Intravenous REOLYSIN (Wild-typ...
(Date:11/6/2009)...da for Arrowhead’s 2010 Personalized Medicin...ace on February 22-24, 2010 in Philadelphia, has b...l highlight key issues in forming partnerships and...es. , Minneapolis, MN (PR...rsquo;s 2010 Personalized Medicine Partnerships C...
(Date:11/5/2009)...RNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNV...third quarter ended September 30, 2009. GenVec rep... for the three months ended September 30, 2009 com...re) in the comparable quarter of 2008. For the nin...ss was $14.1 million ($0.15 per share), compared t...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Biosciences announces,an enhanced matching funds ...n in genomics. $1.75 million in matching funds is ... to each qualifying institution. The,Genomics Educ... streamlined,application process to help colleges ...ndergraduate students studying molecular biology a...
...n combats an,alarming rise in chronic diseases, th...rica (PhRMA) today released a new report on the ne...hat offer hope to millions,of patients., The repo...d,biotechnology companies - including several loca...tech medicines., Today,s report was released in M...
...ble Oils has reached a,key milestone in its effort...tunities for Montana farmers. The company received... a department of the Federal Drug,Administration, ...ot beef,cattle and growing swine up to 2 percent o... a by-product of camelina oil extraction., Sustai...
Other Biology Technology:New Report on 633 Biotechnology Medicines Under Development Released in Michigan 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 3Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 2Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 3
...highly photostable FluoSpheres microspheres have e...ions requiring probes that can deliver a strong si...ule-labeled microspheres have hydrophobic regions ... in some applications. This nonspecific binding ca...
DNA Polymerase I Large (Klenow) Fragment from Invitrogen
...Proteinase K is a highly active and stable endopep...ed from the fungus T. album. It cleaves peptide bo...ituted hydrophobic aliphatic and aromatic amino ac...roteinase K is useful in purifying high molecular ...
Combiplate 8 from Thermo Scientific
Biology Products: